To date, hundreds of mutations in TYR and OCA2 have been reported in OCA patients [24]; most of the relevant studies have determined mutation pathogenicity on the basis of cosegregation analysis or computational prediction. The gene discussed is OCA2; the disease is oculocutaneous albinism.